Search

everythinglearnresearchcommunity

for

Search:↓

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Tislelizumab can cause cutaneous lupus erythematosus.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

CD90 is abundantly present on stem-like cells in dog hair follicles.

CDK4 levels affect the number of hair follicle stem cells in mice.

A specific group of slow-growing stem cells marked by Thy1 is crucial for skin maintenance and healing in mice.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.